AGREEMENT BETWEENAgreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories
EXHIBIT 10.16 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN REDACTED PROVISIONS OF THIS AGREEMENT. THE REDACTED PROVISIONS ARE IDENTIFIED BY THREE ASTERISKS ENCLOSED BY BRACKETS AND UNDERLINED. THE CONFIDENTIAL PORTION HAS BEEN FILED...Services Agreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories
PREAMBLELicense Agreement • December 1st, 2000 • Specialty Laboratories • Services-medical laboratories • California
BY AND AMONGAsset Purchase Agreement • March 30th, 2001 • Specialty Laboratories • Services-medical laboratories • California
BORROWER'S COPY --------------- June 26, 1996Loan Agreement • September 12th, 2000 • Specialty Laboratories • California
Shares of Common StockSpecialty Laboratories • December 1st, 2000 • Services-medical laboratories • New York
Exhibit 10.24 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is entered into as of September 1, 2000 by and between Specialty Laboratories, Inc., a California Company (the "Company"), and John W. Littleton ("Executive"), and is effective upon approval...Employment Agreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories • California
AGREEMENTAgreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories • New Jersey
EXHIBIT 10.27A EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is entered into as of October 12, 2000 by and between Specialty Laboratories, Inc., a California Company (the "Company"), and Frank J. Spina ("Executive"), and is effective upon approval of...Employment Agreement • November 13th, 2000 • Specialty Laboratories • Services-medical laboratories • California
EXHIBIT 10.22 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is entered into as of September 1, 2000 by and between Specialty Laboratories, Inc., a California Company (the "Company"), and James B. Peter M.D., Ph.D. ("Executive"), and is effective upon...Employment Agreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories • California
LOGO] ADDENDUM TO STANDARD INDUSTRIAL LEASESpecialty Laboratories • September 12th, 2000
EXHIBIT 10.25 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is entered into as of September 1, 2000 by and between Specialty Laboratories, Inc., a California Company (the "Company"), and Bart E. Thielen ("Executive"), and is effective upon approval...Employment Agreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories • California
CONFIDENTIALPurchase and License Agreement • December 5th, 2000 • Specialty Laboratories • Services-medical laboratories • California
EXHIBIT 10.30A CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN REDACTED PROVISIONS OF THIS AGREEMENT. THE REDACTED PROVISIONS ARE IDENTIFIED BY THREE ASTERISKS ENCLOSED BY BRACKETS AND UNDERLINED. THE CONFIDENTIAL PORTION HAS BEEN FILED...And License Agreement • December 1st, 2000 • Specialty Laboratories • Services-medical laboratories • Washington
STANDARD FORM SUBLEASELease • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories • California
EMPLOYMENT AGREEMENTEmployment Agreement • August 9th, 2005 • Specialty Laboratories Inc • Services-medical laboratories • California
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 25, 2005, by and between Specialty Laboratories, Inc., a California corporation (the “Company”), and David C. Weavil (“Executive”), and is effective upon execution by the Executive and approval by the Company’s Board of Directors (the “Board”).
TERM NOTE B-2Specialty Laboratories • September 12th, 2000 • Michigan
AGREEMENTAgreement • December 1st, 2000 • Specialty Laboratories • Services-medical laboratories • New York
AMERINET, INC. GROUP PURCHASING AGREEMENT Between AMERINET, INC. AndGroup Purchasing Agreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories
FINANCING AGREEMENT THE CIT GROUP/BUSINESS CREDIT, INC. (as Lender) And SPECIALTY LABORATORIES, INC. (as Borrower) Dated: September 24, 2003Financing Agreement • November 14th, 2003 • Specialty Laboratories Inc • Services-medical laboratories
THE CIT GROUP/BUSINESS CREDIT, INC., a New York corporation, with offices located at 300 South Grand Avenue, 3rd Floor, Los Angeles, California 90071 (hereinafter “CIT”), is pleased to confirm the terms and conditions under which CIT shall make revolving loans and other financial accommodations to Specialty Laboratories, Inc., a California corporation with a principal place of business at 1620 26th Street, 5th Floor, South Tower, Santa Monica, California 90404 (herein the “Company”).
BY AND BETWEEN JOINT PURCHASING CORPORATION AND SPECIALTY LABORATORIES, INC. CONTRACT # 1234Laboratory Services Agreement • October 10th, 2000 • Specialty Laboratories • Services-medical laboratories • New York
SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMSSeparation Agreement and Release • August 13th, 2002 • Specialty Laboratories • Services-medical laboratories
This Separation Agreement and Release of All Claims ("Agreement") is voluntarily entered into by Shoji Maruyama ("Employee") and Specialty Laboratories, Inc. ("Specialty" or "Company") to settle fully and finally all obligations and/or differences between them, disputed and/or undisputed, arising out of, relating to or resulting from Employee's employment with Specialty and separation from employment. Employee and Specialty agree:
LABORATORY SERVICES AGREEMENT BY AND BETWEEN SPECIALTY LABORATORIES, INC. AND UNILAB CORPORATIONLaboratory Services Agreement • October 16th, 2000 • Specialty Laboratories • Services-medical laboratories • California
LOGO] THIRD WAVE TECHNOLOGIESLetter Agreement • December 1st, 2000 • Specialty Laboratories • Services-medical laboratories • Wisconsin
LOGO]Lease • September 12th, 2000 • Specialty Laboratories
SECURITY AGREEMENTSecurity Agreement • May 7th, 2002 • Specialty Laboratories • Services-medical laboratories • California
THIS SECURITY AGREEMENT (this "Agreement") is made as of March 26, 2002, by Specialty Laboratories, Inc., a California corporation ("Debtor"), in favor of both BNP Paribas and BNP Paribas Leasing Corporation, both individually and as agent (collectively, "Secured Party").
SECOND AMENDMENT TO STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - GROSSSpecialty Laboratories • March 21st, 2003 • Services-medical laboratories
THIS AMENDMENT MADE THIS 22TH DAY OF November, 2002 (the “Amendment”) by and between WDI SANTA MONICA LLC, A CALIFORNIA LIMITED LIABILITY CORPORATION, hereinafter referred to as “Lessor”, and SPECIALTY LABORATORIES, INC., A CALIFORNIA CORPORATION, Hereinafter referred to as “Lessee”.
QuickLinks -- Click here to rapidly navigate through this documentConstruction Management Agreement • May 7th, 2002 • Specialty Laboratories • Services-medical laboratories
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN REDACTED PROVISIONS OF THIS AGREEMENT. THE REDACTED PROVISIONS ARE IDENTIFIED BY THREE ASTERISKS ENCLOSED BY BRACKETS AND UNDERLINED. THE CONFIDENTIAL PORTIONS HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
OFFICE LEASE THE WATER GARDEN WATER GARDEN COMPANY L.L.C., a Delaware limited liability company, as Landlord, and SPECIALTY LABORATORIES, INC. a California corporation as Tenant.Specialty Laboratories Inc • March 15th, 2004 • Services-medical laboratories • California
This Office Lease, which includes the preceding Summary of Basic Lease Information (the "Summary") attached hereto and incorporated herein by this reference (the Office Lease and Summary are sometimes collectively referred to herein as the "Lease"), dated as of the date set forth in Section 1 of the Summary is made by and between WATER GARDEN COMPANY L.L.C., a Delaware limited liability company ("Landlord"), and SPECIALTY LABORATORIES, INC., a California corporation ("Tenant").
August 15, 2003Specialty Laboratories Inc • November 14th, 2003 • Services-medical laboratories
Chiron Corporation (“Chiron”) agrees that it shall not assert its Hepatitis C (“HCV”) and HIV-1 patent rights (“Patent Rights”) in any action, suit or other proceeding seeking to recover against Specialty Laboratories, Inc. (“Specialty”) for the performance of nucleic acid testing (“NAT”) clinical assay(s) for the detection, quantitation, genotyping and/or phenotyping of HCV and HIV-1 and/or the provision of the results thereof to third parties (the “Testing Activity”), occurring at any time prior to October 15, 2003 (the “Effective Date”).
CONSULTING AGREEMENTConsulting Agreement • March 15th, 2005 • Specialty Laboratories Inc • Services-medical laboratories • California
This Consulting Agreement (“Agreement”) confirms the understanding between David Schreiber (“Schreiber”) and Specialty Laboratories, Inc., a California corporation with its principal offices at 27027 Tourney Road, Valencia, California, 91355 (the “Company”), pursuant to which the Company has agreed to retain Schreiber to provide consulting services of the type described below (collectively, the “Services”), on the terms and subject to the conditions set forth herein, in connection with the matters referred to herein.
PURCHASE AGREEMENT BETWEEN BNP PARIBAS LEASING CORPORATION ("BNPPLC") AND SPECIALTY LABORATORIES, INC. ("Specialty Laboratories") March 26, 2002 (Santa Clarita, California)Purchase Agreement • May 7th, 2002 • Specialty Laboratories • Services-medical laboratories • California
LEASE AGREEMENT BETWEEN BNP PARIBAS LEASING CORPORATION ("BNPPLC") AND SPECIALTY LABORATORIES, INC. ("Specialty Laboratories") March 26, 2002 (Santa Clarita, California)Iii Lease Agreement • May 7th, 2002 • Specialty Laboratories • Services-medical laboratories
This LEASE AGREEMENT (this "Lease") is made and dated as of March 26, 2002 (the "Effective Date") by and between BNP PARIBAS LEASING CORPORATION, a Delaware corporation ("BNPPLC"), and SPECIALTY LABORATORIES, INC., a California corporation ("Specialty Laboratories").
PLEDGE AGREEMENT AMONG BNP PARIBAS LEASING CORPORATION ("BNPPLC") BNP PARIBAS, AS AGENT ("Agent") SPECIALTY LABORATORIES, INC. ("Specialty Laboratories") AND PARTICIPANTS AS DESCRIBED HEREIN March 26, 2002Pledge Agreement • May 7th, 2002 • Specialty Laboratories • Services-medical laboratories
This PLEDGE AGREEMENT (this "Agreement") is made as of March 26, 2002 (the "Effective Date"), by SPECIALTY LABORATORIES, INC., a California corporation ("Specialty Laboratories"); BNP PARIBAS LEASING CORPORATION, a Delaware corporation ("BNPPLC"); BNP PARIBAS ("BNPPLC's Parent"), as a "Participant"; BNP PARIBAS, acting in its capacity as agent for BNPPLC and the Participants (in such capacity, "Agent"), and each of the other Participants hereto, and is made and dated as of the Effective Date.
SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMSSeparation Agreement and Release • May 12th, 2004 • Specialty Laboratories Inc • Services-medical laboratories
This Separation Agreement and Release of All Claims (“Agreement”) is voluntarily entered into by Frank J. Spina (“Employee”) and Specialty Laboratories, Inc. (“Specialty” or “Company”) to settle fully and finally all obligations and/or differences between them, disputed and/or undisputed, arising out of, relating to or resulting from Employee’s employment with Specialty and separation from employment. Employee and Specialty agree:
